Heparin Market

Heparin Market - Size, Share, Outlook, and
Opportunity Analysis, 2018 - 2026
Heparin is used to prevent or treat certain blood vessel, heart, and lung conditions. It is also
used in blood transfusion, blood samplings during prophylaxis treatment, and for treatment of
blood clotting disorders Heparin may be used to diagnose and treat a serious blood condition
called disseminated intravascular coagulation. Heparin is sometimes used alone or in
combination with aspirin to prevent pregnancy loss and other problems.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2602
The global heparin market size was valued at US$ 9.4 billion in 2017 and is expected to
witness a CAGR of 5.1% over the forecast period (2018 – 2026).
Market Dynamics
Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein
thrombosis is one of the major factors for increased demand of heparin drugs in the market.
Myocardial infarction (MI) is one of the major complications of coronary heart disease.
According to the American Heart Association 2018 report, coronary heart disease is the leading
cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%).
As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis
affects nearly 900,000 individuals in the U.S. each year.
Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine,
therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a
significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions
such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity
reactions. These factors can hamper the heparin market, during the forecast period.
Increasing incidences of coronary heart disease, pulmonary embolism, and deep vein thrombosis
is expected to drive growth of the heparin market
Heparin is widely used clinically for dialysis, deep vein thrombosis (DVT) treatment, and most
cardiac surgeries. It is also used to prevent blood clotting during open-heart surgery, kidney
dialysis, bypass surgery, and blood transfusions. Kidney dialysis procedure is increasing with
rising chronic kidney disease, worldwide. For instance, according to Kidney Care UK 2016
report, about 3 million people in the U.K. are suffering from chronic kidney disease (CKD).
Report includes chapters which deeply display the following deliverable about industry :
• Heparin Market Research Objective and Assumption
• Heparin Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Heparin Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Heparin Market, By Regions
• Heparin Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Heparin Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Heparin Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Heparin Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2602
Heparin Market - Competitive Landscape
Key players operating in the global heparin market include Anselm Pharmaceuticals, Baxter
International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories
Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A.,
Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Heparin is an anticoagulant used to decrease the clotting ability of blood and help to prevent harmful clots from forming in blood vessels.

Download Report